TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Expected to Post FY2025 Earnings of ($0.27) Per Share

TRACON Pharmaceuticals, Inc. (NASDAQ:TCON – Free Report) – Research analysts at HC Wainwright reduced their FY2025 earnings per share estimates for shares of TRACON Pharmaceuticals in a report released on Wednesday, April 3rd. HC Wainwright analyst E. White now expects that the biopharmaceutical company will earn ($0.27) per share for the year, down from their […]

Related Keywords

United States , ,Nasdaq ,Pharmaceuticals Daily ,Tracon Pharmaceuticals Inc ,Virtu Financial ,Ci Private Wealth ,Pharmaceuticals Trading Down ,Pharmaceuticals Inc ,Susquehanna International Group ,Charles Schwab Investment Management Inc ,Free Report ,Trading Down ,Get Free Report ,Street Group ,Schwab Investment Management ,International Group ,Tracon Pharmaceuticals ,Nasdaq Tcon ,Ltcon ,Medical ,Earnings Estimates ,Hc Wainwright ,